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1. Materials and Methods 
 Unless otherwise stated, reactions were performed under a nitrogen atmosphere using 
freshly dried solvents. Methylene chloride (CH2Cl2), diethyl ether (Et2O), tetrahydrofuran (THF), 
1,4-dioxane, tert-butyl methyl ether (TBME), and toluene (PhMe) were dried by passing through 
activated alumina columns. Methanol (MeOH) was distilled over calcium hydride. Acetonitrile 
(MeCN), tert-butanol (t-BuOH), anhydrous N,N-dimethylformamide (DMF), anhydrous N,N-
dimethylacetamide (DMA), chloroform (CHCl3), and absolute ethanol (EtOH) were used as 
received from Fisher Scientific. Methyl vinyl ketone was dried over K2CO3 and CaCl2 and then 
distilled immediately prior to use. K2HPO4 was flame-dried under vacuum and dried at 0.200 Torr 
overnight and stored in a dessicator. Aryl iodides were purchased from Sigma-Aldrich or Combi-
Blocks or prepared according to literature procedures. NiBr2•dme and NiCl2•dme were purchased 
from Strem and stored in a N2-filled glovebox. Zinc dust and Pd(OAc)2 were purchased from Strem 
and stored in a dessicator. Ir[dF(CF3)ppy]2(dtbbpy)PF6 was purchased from Oakwood chemicals 
and used as received. Pd(PPh3)4 and Cs2CO3 were purchased from Sigma-Aldrich and stored in a 
N2-filled glovebox. All other commercially obtained reagents were purchased from Sigma-Aldrich 
and used as received unless specifically indicated. Photochemical reactions were conducted using 
either Kessil A160WE blue LED lamps positioned 3–6 cm from the reactions using a computer 
fan to keep the reactions at ambient temperature, or 12W blue LED strips lining a beaker wrapped 
in aluminum foil . Yields of arylation reactions reported are an average of two runs. All reactions 
were monitored by thin-layer chromatography using EMD/Merck silica gel 60 F254 pre-coated 
plates (0.25 mm). Silica gel and basic alumina column chromatography was performed as 
described by Still et al. (W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923.) using silica 
gel (particle size 0.032–0.063) purchased from Silicycle and aluminum oxide (activated, basic, 
Brockmann I, 58 Å pore size, powder) purchased from Sigma-Aldrich. 1H and 13C NMR were 
recorded on a Varian Inova 500 (at 500 MHz and 125 MHz respectively) or a Bruker Avance III 
HD with Prodigy cyroprobe (at 400 MHz and 101 MHz respectively). 19F NMR spectra were 
recorded on a Varian Inova 400 (at 376 MHz). NMR data is reported relative to internal chloroform 
(1H, δ = 7.26, 13C, δ = 77.2) or to internal methanol (1H, δ = 3.31, 13C, δ = 49.0) and PhCF3 (19F, δ 
= –63.7).  Data for 1H NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, 
coupling constant (Hz), integration). Multiplicity and qualifier abbreviations are as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet. IR spectra were recorded on a Perkin 
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Elmer Paragon 1000 spectrometer and are reported in frequency of absorption (cm–1). HRMS were 
acquired using either an Agilent 6200 Series TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), or mixed (MM) 
ionization mode. Specific optical rotations were recorded on a Jasco P-2000 polarimeter using a 
100 mm cell. 
Abbreviations used: Et2O – diethyl ether; CH2Cl2 – methylene chloride;   PhMe – toluene; EtOAc 
– ethyl acetate; THF – tetrahydrofuran; t-BuOH – tert-butanol; CHCl3 – chloroform; MeCN – 
acetonitrile; DMF – N,N-dimethylformamide; DMA – N,N-dimethylacetamide; dtbbpy – 4,4’-
ditertbutylbipyridine; dme – 1,2-dimethoxyethane; TBME – tert-butyl methyl ether; ABNO – 9-
azabicyclo[3.3.1]nonane N-oxyl. 
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2. Csp3–H arylation 
a. General Procedure 
On the bench-top, a 2-dram vial equipped with a stir bar was charged with Pd(OAc)2 (15 mol %, 
0.03 mmol), Ag2CO3 (1 equiv, 0.2 mmol), cyclobutamide (4) (1 equiv, 0.2 mmol), and aryl iodide 
(2 equiv, 0.4 mmol). TBME (0.2 M, 1 mL) was added to the vial, then the vial was sealed with a 
Teflon cap and electrical tape and submerged in an oil bath at 90 °C. After approximately 5 minutes 
for aryl iodide substrates and 30 minutes for heteroaryl iodide substrates, the olive-green mixture 
became black. The reaction mixture was stirred at 90 °C additional 16 hours, at which point the 
vial is allowed to cool to room temperature over 15 minutes. The black reaction mixture was 
diluted with CH2Cl2 and filtered over a pad of 20 grams of tightly packed celite. The celite plug 
was eluted with an additional 100 mL of CH2Cl2. Following this, the resultant orange solution was 
concentrated in vacuo and subsequently purified by silica gel column chromatography to give the 
arylated cyclobutane products. (Note: some substrates required purification with basic alumina as 
the stationary phase).  
d. Characterization of Arylation Products 
 
9a 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 2-
iodoanisole (2 equiv, 93.6 mg, 0.4 mmol). The crude residue was 
purified by column chromatography (10 → 15 → 20% 
EtOAc/Hexanes) to give a colorless foam. 
Run 1: (54.4 mg, 75%), Run 2: (61.2 mg, 84%) 
Rf = 0.48 (silica gel, 30% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +84.8° (c = 3.3, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.57 (s, 1H), 8.77 (dd, J = 4.2, 1.7 Hz, 1H), 8.60 (dd, J = 4.9, 4.2 
Hz, 1H), 8.10 (dd, J = 8.3, 1.7 Hz, 1H), 7.44 – 7.36 (m, 3H), 7.24 (dt, J = 7.4, 1.5 Hz, 1H), 7.09 
(dddd, J = 8.2, 7.4, 1.8, 0.8 Hz, 1H), 6.96 (tdd, J = 7.5, 1.1, 0.4 Hz, 1H), 6.61 (dd, J = 8.1, 1.1 Hz, 
1H), 4.09 – 3.95 (m, 1H), 3.62 (s, 3H), 3.46 (ddd, J = 8.6, 2.9, 0.8 Hz, 1H), 2.74 (t, J = 10.8 Hz, 
1H), 2.13 (ddd, J = 10.4, 8.4, 2.9 Hz, 1H), 1.53 (s, 3H), 1.22 (s, 3H). 
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 13C NMR (101 MHz, CDCl3):  δ 171.13, 157.19, 147.90, 138.41, 136.31, 134.88, 130.18, 127.92, 
127.66, 127.54, 127.00, 121.45, 120.75, 120.43, 116.27, 109.43, 58.05, 55.05, 37.10, 35.89, 32.81, 
30.33, 25.14. 
FTIR (NaCl, thin film, cm-1): 3366, 2952, 5927, 2863, 2361, 1685, 1523, 1485, 1464, 1424, 1324, 
1241, 1161, 1132, 1161, 1029, 826, 792, 751. 
HRMS (ESI-TOF, m/z): calc’d for C23H25N2O2 [M+H]+: 361.1911; found: 361.1925. 
 
9b 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 3-
iodoanisole (2 equiv, 93.6 mg, 0.4 mmol). The crude residue was 
purified by column chromatography (10 → 15 → 20% 
EtOAc/Hexanes) to give a white solid. 
Run 1: (59.0 mg, 82%), Run 2: (58.3 mg, 81%) 
Rf = 0.36 (silica gel, 20% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +61.6° (c = 0.4, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.62 (s, 1H), 8.75 (dd, J = 4.2, 1.7 Hz, 1H), 8.64 (p, J = 4.3 Hz, 
1H), 8.11 (dd, J = 8.3, 1.7 Hz, 1H), 7.45 – 7.38 (m, 3H), 7.13 (t, J = 7.9 Hz, 1H), 6.82 (ddt, J = 
7.6, 1.8, 1.0 Hz, 1H), 6.77 (dt, J = 2.7, 1.3 Hz, 1H), 6.63 (ddt, J = 8.2, 2.6, 0.9 Hz, 1H), 4.03 (dtd, 
J = 11.0, 8.6, 1.1 Hz, 1H), 3.67 (s, 3H), 3.39 (ddd, J = 8.7, 2.9, 0.8 Hz, 1H), 2.76 (t, J = 10.7 Hz, 
1H), 2.16 (ddd, J = 10.4, 8.5, 3.0 Hz, 1H), 1.51 (s, 3H), 1.22 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.5, 159.5, 148.0, 143.7, 138.4, 136.4, 134.6, 129.1, 127.9, 
127.5, 121.5, 121.2, 119.1, 116.5, 112.3, 111.3, 57.7, 55.1, 37.8, 36.0, 35.8, 30.2, 25.1. 
FTIR (NaCl, thin film, cm-1): 3357, 2952, 2925, 1684, 1600, 1582, 1521, 1485, 1424, 1386, 1323, 
1259, 1160, 1049, 878, 826, 790, 756, 694. 
HRMS (ESI-TOF, m/z): calc’d for C23H25N2O2 [M+H]+: 361.1911; found: 361.1915. 
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9c 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 4-
iodoanisole (2 equiv, 93.6 mg, 0.4 mmol). The crude residue was 
purified by column chromatography (10 → 15% EtOAc/Hexanes) to 
give a white, amorphous solid. 
Run 1: (47.7 mg, 66%), Run 2: (51.2 mg, 71%) 
Rf = 0.23 (silica gel, 20% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +59.8° (c = 1.3, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.58 (s, 1H), 8.75 (dd, J = 4.2, 1.7 Hz, 1H), 8.63 (p, J = 4.4 Hz, 
1H), 8.10 (dd, J = 8.3, 1.7 Hz, 1H), 7.45 – 7.38 (m, 3H), 7.20 – 7.13 (m, 2H), 6.80 – 6.73 (m, 2H), 
4.00 (q, J = 11.1, 8.6 Hz, 1H), 3.70 (s, 3H), 3.34 (ddd, J = 8.7, 3.0, 0.8 Hz, 1H), 2.75 (t, J = 10.8 
Hz, 1H), 2.13 (ddd, J = 10.4, 8.6, 3.0 Hz, 1H), 1.51 (s, 3H), 1.23 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.6, 157.7, 148.0, 138.4, 136.4, 134.6, 133.7, 127.9, 127.5, 
121.5, 121.1, 116.5, 113.6, 57.7, 55.3, 37.9, 35.7, 35.5, 30.2, 25.2. 
FTIR (NaCl, thin film, cm-1): 2926, 2361, 1685, 1523, 1485, 1288, 1324, 1247, 1160, 1038, 
826, 772. 
HRMS (ESI-TOF, m/z): calc’d for C23H25N2O2 [M+H]+: 361.1911; found: 361.1921. 
 
9d 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 4-
iodotoluene (2 equiv, 87.2 mg, 0.4 mmol). The crude residue was 
purified by column chromatography (10 → 15 → 20% 
EtOAc/Hexanes) to give a white, amorphous solid. 
Run 1: (54.1 mg, 79%), Run 2: (55.9 mg, 81%) 
Rf = 0.29 (silica gel, 20% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +54.2° (c = 2.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.60 (s, 1H), 8.76 (dd, J = 4.2, 1.7 Hz, 1H), 8.65 (h, J = 4.2 Hz, 
1H), 8.11 (dd, J = 8.2, 1.7 Hz, 1H), 7.50 – 7.36 (m, 3H), 7.14 (d, J = 7.8 Hz, 2H), 7.02 (d, J = 7.4 
Hz, 2H), 4.01 (td, J = 10.8, 8.1 Hz, 1H), 3.37 (ddd, J = 8.7, 2.9, 0.8 Hz, 1H), 2.76 (t, J = 10.8 Hz, 
1H), 2.24 (s, 3H), 2.14 (ddd, J = 10.4, 8.6, 2.9 Hz, 1H), 1.51 (s, 3H), 1.22 (s, 3H). 
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13C NMR (101 MHz, CDCl3): δ 170.6, 148.0, 138.7, 138.4, 136.4, 135.0, 134.7, 128.9, 127.9, 
127.5, 126.7, 121.5, 121.1, 116.5, 57.7, 37.8, 35.8, 35.7, 30.2, 25.2, 21.2. 
FTIR (NaCl, thin film, cm-1): 3360, 2924, 2359, 1686, 1522 1485, 1424, 1386, 1324, 1160, 
826, 792. 
HRMS (ESI-TOF, m/z): calc’d for C23H25N2O [M+H]+: 345.1961; found: 345.1971. 
9e 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 2-
iodobenzonitrile (2 equiv, 91.8 mg, 0.4 mmol). The crude residue was 
purified by column chromatography (10 → 15% EtOAc/Hexanes) to 
give a pale, yellow foam. 
Run 1: (57.6 mg, 81%), Run 2: (64.7 mg, 91%) 
Rf = 0.55 (silica gel, 30% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = –24.4° (c = 5.4, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.76 (s, 1H), 8.81 (dd, J = 4.2, 1.7 Hz, 1H), 8.53 (dd, J = 7.4, 1.7 
Hz, 1H), 8.10 (dd, J = 8.3, 1.7 Hz, 1H), 7.56 (td, J = 8.0, 7.6, 1.2 Hz, 1H), 7.51 – 7.35 (m, 5H), 
7.21 (tdd, J = 7.6, 1.3, 0.7 Hz, 1H), 4.21 (dt, J = 11.1, 8.3, 7.8 Hz, 1H), 3.74 (ddd, J = 8.3, 3.0, 0.8 
Hz, 1H), 2.87 (t, J = 10.7 Hz, 1H), 2.16 (ddd, J = 10.4, 8.3, 3.1 Hz, 1H), 1.57 (s, 3H), 1.20 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.0, 148.3, 146.9, 138.5, 136.3, 134.5, 132.6, 128.1, 127.9, 
127.2, 126.3, 121.7, 121.4, 118.8, 116.3, 110.6, 57.7, 36.6, 36.1, 35.2, 29.8, 25.1. 
FTIR (NaCl, thin film, cm-1): 3353, 2954, 2361, 2222, 1683, 1523, 1485, 1424, 1388, 1323, 1260, 
1161, 826, 791, 755, 668. 
HRMS (ESI-TOF, m/z): calc’d for C23H21N3O [M+H]+: 356.1757; found: 356.1773. 
9f 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 4-
iodobenzonitrile (2 equiv, 91.8 mg, 0.4 mmol). The crude residue was 
purified by column chromatography (10 → 15 → 20 →25 % 
EtOAc/Hexanes) to give a pale, yellow foam. 
Run 1: (50.5 mg, 71%), Run 2: (53.3 mg, 75%) 
Rf = 0.32 (silica gel, 30% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +102.7° (c = 5.1, CHCl3). 
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1H NMR (400 MHz, CDCl3): δ 9.66 (s, 1H), 8.79 (dd, J = 4.2, 1.7 Hz, 1H), 8.56 (dd, J = 7.2, 1.8 
Hz, 1H), 8.14 (dd, J = 8.3, 1.7 Hz, 1H), 7.50 (dt, J = 8.3, 1.8 Hz, 2H), 7.49 – 7.37 (m, 3H), 7.33 – 
7.24 (m, 2H), 4.02 (dt, J = 10.8, 8.3 Hz, 1H), 3.43 (ddd, J = 8.5, 3.0, 0.8 Hz, 1H), 2.77 (t, J = 10.7 
Hz, 1H), 2.18 (ddd, J = 10.4, 8.5, 3.0 Hz, 1H), 1.53 (s, 3H), 1.20 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 169.9, 148.4, 148.2, 138.3, 136.5, 134.2, 131.9, 128.0, 127.5, 
127.3, 121.7, 121.6, 119.5, 116.5, 109.3, 57.7, 37.5, 36.1, 36.0, 29.9, 25.0. 
FTIR (NaCl, thin film, cm-1): 3353, 2954, 2930, 2361, 2226, 1684, 1608, 1524, 1486, 1424, 
1288, 1323, 1161, 826, 792, 755, 668. 
HRMS (ESI-TOF, m/z): calc’d for C23H22N3O [M+H]+: 356.1757; found: 356.1752. 
9g 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 3-
iodotrifluorotoluene (2 equiv, 109.1 mg, 0.4 mmol). The crude residue 
was purified by column chromatography (10% EtOAc/Hexanes) to 
give a colorless oil. 
Run 1: (67.7 mg, 85%), Run 2: (62.9 mg, 79%) 
Rf = 0.23 (silica gel, 20% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +47.3° (c = 3.3, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.63 (s, 1H), 8.77 (dd, J = 4.2, 1.7 Hz, 1H), 8.57 (dd, J = 6.6, 2.4 
Hz, 1H), 8.12 (dd, J = 8.3, 1.7 Hz, 1H), 7.50 – 7.36 (m, 5H), 7.39 – 7.26 (m, 2H), 4.05 (dt, J = 
11.0, 8.7 Hz, 1H), 3.42 (ddd, J = 8.6, 3.0, 0.8 Hz, 1H), 2.80 (t, J = 10.8 Hz, 1H), 2.20 (ddd, J = 
10.4, 8.5, 3.0 Hz, 1H), 1.53 (s, 3H), 1.23 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.2, 148.2, 143.2, 138.5, 136.6, 134.5, 130.4 (q, JC–F = 32 Hz), 
130.3, 128.5, 128.1, 127.6, 125.9, 123.7 (q, JC–F = 3.7 Hz), 123.2, 122.8 (q, JC–F = 3.8 Hz), 121.7, 
121.5, 116.6, 57.8, 37.8, 36.1, 36.0, 30.2, 30.0, 25.2. 
19F NMR (376 MHz, CDCl3) δ -63.50. 
FTIR (NaCl, thin film, cm-1): 3355, 2931, 2360, 1684, 1523, 1486, 1425, 1388, 1324, 1162, 
1122, 1072, 901, 826, 793, 756, 701, 659. 
HRMS (ESI-TOF, m/z): calc’d for C23H22F3N2O [M+H]+: 399.1679; found: 399.1679. 
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9h 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 4-
iodoacetophenone (2 equiv, 98.7 mg, 0.4 mmol). The crude residue 
was purified by column chromatography (20% EtOAc/Hexanes) to 
give a white, amorphous solid. 
Run 1: (57.3 mg, 77%), Run 2: (56.6 mg, 76%) 
Rf = 0.41 (silica gel, 40% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +95.0° (c = 3.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.73 (s, 1H), 8.85 (dd, J = 4.3, 1.7 Hz, 1H), 8.66 (dd, J = 7.1, 1.8 
Hz, 1H), 8.20 (dd, J = 8.3, 1.7 Hz, 1H), 7.94 – 7.87 (m, 2H), 7.51 (dd, J = 8.5, 4.1 Hz, 2H), 7.48 
(q, J = 9.2, 8.2, 8.2 Hz, 1H), 7.39 – 7.33 (m, 2H), 4.12 (td, J = 11.3, 9.7, 8.4 Hz, 1H), 3.51 (ddd, J 
= 8.6, 2.9, 0.8 Hz, 1H), 2.88 (t, J = 10.7 Hz, 1H), 2.58 (s, 3H), 2.26 (ddd, J = 10.3, 8.5, 3.0 Hz, 
1H), 1.61 (s, 3H), 1.29 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 198.1, 170.1, 148.5, 148.1, 138.4, 136.5, 134.8, 134.4, 128.4, 
128.0, 127.5, 126.7, 121.6, 121.4, 116.5, 57.8, 37.7, 36.1, 36.0, 30.0, 26.7, 25.1. 
FTIR (NaCl, thin film, cm-1): 3354, 2954, 2928, 2866, 1678, 1606, 1523, 1485, 1424, 1387, 
1323, 1267, 1161, 956, 826, 792, 754, 657. 
HRMS (ESI-TOF, m/z): calc’d for C24H25N2O2 [M+H]+: 373.1911; found: 373.1900. 
9i 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 2-
fluoro-3-iodopyridine (2 equiv, 89.2 mg, 0.4 mmol). The crude residue 
was purified by column chromatography using silica gel basified with 
4 mL of aqueous ammonium hydroxide (10% EtOAc/2% Et3N/88% 
hexanes → 15% EtOAc/2% Et3N/83% hexanes → 20% EtOAc/2% 
Et3N/78% hexanes → 35% EtOAc/2% Et3N/63% hexanes) to give a white foam. 
Run 1: (56.1 mg, 80%), Run 2: (56.4 mg, 81%) 
Rf = 0.22 (silica gel, 20% EtOAc/Hex, UV, p-Anisaldehyde). 
[α]D25 = +60.8° (c = 0.415, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.66 (s, 1H), 8.77 (dd, J = 4.3, 1.7 Hz, 1H), 8.54 (dd, J = 7.0, 2.1 
Hz, 1H), 8.09 (dd, J = 8.3, 1.7 Hz, 1H), 7.96 (ddt, J = 4.9, 2.0, 1.0 Hz, 1H), 7.72 (ddq, J = 9.9, 7.5, 
1.2, 0.7 Hz, 1H), 7.45 – 7.34 (m, 3H), 7.15 (ddd, J = 7.1, 4.9, 1.9 Hz, 1H), 3.99 (dtd, J = 11.0, 8.6, 
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1.1 Hz, 1H), 3.44 (ddt, J = 8.4, 2.5, 1.3 Hz, 1H), 2.76 (t, J = 10.7 Hz, 1H), 2.11 (ddd, J = 10.4, 8.4, 
3.0 Hz, 1H), 1.53 (s, 3H), 1.19 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.2, 161.5 (d, JC–F = 237 Hz), 148.2, 144.6 (d, JC–F = 14.7 Hz), 
139.3 (d, JC–F = 6.1 Hz), 138.4, 136.3, 134.4, 127.9, 127.3, 124.2 (d, JC–F = 31.2 Hz), 121.6, 121.4, 
121.3 (d, JC–F = 4.0 Hz), 116.4, 57.0, 36.4 (d, JC–F = 14.8 Hz), 30.8, 30.7, 29.8, 25.0. 
 19F NMR (376 MHz, CDCl3): δ -71.52 (d, J = 10.1 Hz).        
FTIR (NaCl, thin film, cm-1): 3355, 3058, 2954, 2930, 2866, 1682, 1605, 1577, 1524, 1486, 1431, 
1388, 1372, 1324, 1261, 1240, 1162, 1132, 1112, 826, 793, 758. 
HRMS (ESI-TOF, m/z): calc’d for C21H21FN3O [M+H]+: 350.1663; found: 350.1659. 
9j 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 5-
iodo-2-chloropyridine (2 equiv, 95.8 mg, 0.4 mmol). The crude residue 
was purified by column chromatography using basic alumina as the 
stationary phase (0 → 1% MeOH/CH2Cl2) to give a colorless foam. 
Run 1: (50.6 mg, 69%), Run 2: (49.7 mg, 68%) 
Rf = 0.24 (silica gel, 40% EtOAc/Hex, UV). 
[α]D25 = +81.1° (c = 4.3, CHCl3). 
1H NMR (500 MHz, CDCl3): δ 9.64 (s, 1H), 8.76 (dd, J = 4.2, 1.7 Hz, 1H), 8.58 (dd, J = 6.8, 2.2 
Hz, 1H), 8.22 (dt, J = 2.6, 0.8 Hz, 1H), 8.11 (dd, J = 8.3, 1.7 Hz, 1H), 7.56 (ddd, J = 8.2, 2.5, 0.9 
Hz, 1H), 7.46 – 7.38 (m, 3H), 7.17 (d, J = 8.2 Hz, 1H), 3.96 (q, J = 11.0, 8.5 Hz, 1H), 3.38 (ddd, 
J = 8.5, 3.0, 0.8 Hz, 1H), 2.76 (t, J = 10.7 Hz, 1H), 2.15 (ddd, J = 10.4, 8.5, 3.0 Hz, 1H), 1.52 (s, 
3H), 1.22 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 169.8, 148.8, 148.5, 148.1, 138.3, 137.7, 136.5, 136.3, 134.2, 
127.9, 127.4, 123.5, 121.7, 121.6, 116.5, 57.4, 37.4, 36.3, 33.3, 29.8, 29.8, 25.0. 
FTIR (NaCl, thin film, cm-1): 3350, 2954, 1682, 1524, 1485, 1460, 1424, 1386, 1324, 1260, 1162, 
1133, 1104, 826, 792, 755, 666. 
HRMS (ESI-TOF, m/z): calc’d for C21H21ClN3O [M+H]+: 366.1368; found: 366.1370. 
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9k 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 5-
iodo-2-trifluoromethylpyridine (2 equiv, 95.8 mg, 0.4 mmol). The 
crude residue was purified by column chromatography using silica gel 
basified with 5 mL of aqueous ammonium hydroxide (5% EtOAc/2% 
Et3N/93% hexanes → 10% EtOAc/2% Et3N/88% hexanes → 15% 
EtOAc/2% Et3N/83% hexanes → 20% EtOAc/2% Et3N/78% hexanes) 
to give a pale, yellow foam. 
Run 1: (71.6 mg, 90%), Run 2: (68.2 mg, 85%) 
Rf = 0.19 (silica gel, 20% EtOAc/Hex, UV). 
[α]D25 = +67.7° (c = 4.2, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.61 (s, 1H), 8.69 (dd, J = 4.2, 1.7 Hz, 1H), 8.52 – 8.41 (m, 2H), 
8.04 (dd, J = 8.3, 1.7 Hz, 1H), 7.70 – 7.62 (m, 1H), 7.46 (dd, J = 8.1, 0.7 Hz, 1H), 7.41 – 7.28 (m, 
3H), 3.95 (q, J = 11.0, 8.5 Hz, 1H), 3.37 (ddd, J = 8.4, 2.9, 0.9 Hz, 1H), 2.73 (t, J = 10.7 Hz, 1H), 
2.12 (ddd, J = 10.4, 8.5, 3.0 Hz, 1H). 
13C NMR (101 MHz, CDCl3): δ 169.7, 148.8, 148.2, 145.5 (q, JC–F = 35 Hz), 141.2, 138.3, 136.5, 
135.7, 134.1, 128.0, 127.4, 123.2, 121.7, 120.5, 119.9, 119.9, 119.8, 119.8, 116.5, 57.4, 37.3, 36.5, 
33.7, 29.8, 25.0. 
19F NMR (282 MHz, CDCl3): δ -68.6. 
FTIR (NaCl, thin film, cm-1): 3351, 2957, 1682, 1524, 1486, 1425, 1387, 1340, 1261, 1164, 
1134, 1088, 1030, 826, 792, 756, 667. 
HRMS (ESI-TOF, m/z): calc’d for C22H21F3N3O [M+H]+: 400.1631; found: 400.1621. 
9l 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 5-
iodo-2-methoxypyridine (2 equiv, 94.0 mg, 0.4 mmol). The crude 
residue was purified by column chromatography using silica gel 
basified with 4 mL of aqueous ammonium hydroxide (10% EtOAc/2% 
Et3N/88% hexanes → 15% EtOAc/2% Et3N/83% hexanes → 20% 
EtOAc/2% Et3N/78% hexanes → 30% EtOAc/2% Et3N/68% hexanes) 
to give a white solid. 
Me
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Run 1: (34.9 mg, 48%), Run 2: (36.1 mg, 50%) 
Rf = 0.14 (silica gel, 20% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +61.1° (c = 0.415, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.60 (s, 1H), 8.76 (dd, J = 4.2, 1.7 Hz, 1H), 8.62 (dd, J = 5.3, 3.7 
Hz, 1H), 8.12 (dd, J = 8.3, 1.7 Hz, 1H), 8.01 (dt, J = 2.5, 0.9 Hz, 1H), 7.54 (ddd, J = 8.6, 2.5, 0.7 
Hz, 1H), 7.46 – 7.39 (m, 3H), 6.61 (dd, J = 8.6, 0.7 Hz, 1H), 3.96 (qd, J = 11.0, 8.6, 1.1 Hz, 1H), 
3.84 (s, 3H), 3.33 (ddd, J = 8.7, 2.9, 0.8 Hz, 1H), 2.76 (t, J = 10.8 Hz, 1H), 2.14 (ddd, J = 10.4, 
8.6, 3.0 Hz, 1H), 1.51 (s, 3H), 1.23 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.3, 162.7, 148.1, 145.3, 138.4, 138.0, 136.4, 134.5, 129.6, 
128.0, 127.5, 121.6, 121.4, 116.5, 110.1, 57.6, 53.4, 37.7, 36.1, 33.4, 30.1, 25.1. 
FTIR (NaCl, thin film, cm-1): 3352, 2922, 2850, 2351, 1682, 1606, 1574, 1523, 1494, 1486, 1424, 
1385, 1324, 1285, 1259, 1160, 1132, 1032, 826, 792, 756. 
HRMS (ESI-TOF, m/z): calc’d for C22H24N3O2 [M+H]+: 362.1863; found: 362.1856 
9m 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 4-
iodo-1-indanone (2 equiv, 103.5 mg, 0.4 mmol). The crude residue 
was purified by column chromatography (30% EtOAc/Hexanes) to 
give a pale, yellow foam. 
Run 1: (43.4 mg, 56%), Run 2: (39.7 mg, 52%) 
Rf = 0.32 (silica gel, 40% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +2.0° (c = 5.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.57 (s, 1H), 8.74 (dd, J = 4.3, 1.7 Hz, 1H), 8.54 (dd, J = 7.1, 2.0 
Hz, 1H), 8.10 (dd, J = 8.3, 1.7 Hz, 1H), 7.56 (ddt, J = 17.3, 7.6, 1.1 Hz, 2H), 7.46 – 7.33 (m, 4H), 
4.07 (dt, J = 11.2, 8.4 Hz, 1H), 3.47 (ddd, J = 8.4, 3.0, 0.9 Hz, 1H), 3.10 (ddd, J = 17.1, 7.8, 3.8 
Hz, 1H), 2.98 (ddd, J = 17.1, 7.6, 3.9 Hz, 1H), 2.92 (t, J = 10.8 Hz, 1H), 2.57 (dddd, J = 32.0, 19.4, 
7.8, 3.7 Hz, 2H), 2.18 (ddd, J = 10.5, 8.4, 3.1 Hz, 1H), 1.58 (s, 3H), 1.23 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 207.3, 170.1, 153.3, 148.1, 139.5, 138.3, 136.8, 136.5, 134.2, 
132.9, 127.9, 127.5, 127.4, 121.6, 121.5, 121.4, 116.6, 57.2, 37.0, 36.5, 36.2, 34.1, 30.1, 25.2, 25.1. 
FTIR (NaCl, thin film, cm-1): 3353, 3012, 2954, 2927, 2866, 2359, 1709, 1587, 1523, 1485, 1425, 
1386, 1324, 1265, 1162, 1055, 827, 790, 754, 666. 
HRMS (ESI-TOF, m/z): calc’d for C25H25N2O2 [M+H]+: 385.1911; found: 385.1921. 
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9n 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 6-
iodo-N-Boc-indole (2 equiv, 137 mg, 0.4 mmol). The crude residue 
was purified by column chromatography (10% → 15% 
EtOAc/hexanes) to give a colorless foam. 
Run 1: (56.1 mg, 60%), Run 2: (62.8 mg, 67%) 
Rf = 0.36 (silica gel, 20% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +114.7° (c = 5.7, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.64 (s, 1H), 8.65 (dd, J = 4.2, 1.7 Hz, 1H), 8.60 (dd, J = 6.3, 2.8 
Hz, 1H), 8.08 (dd, J = 8.3, 1.7 Hz, 1H), 8.03 (s, 1H), 7.47 (d, J = 3.7 Hz, 1H), 7.43 – 7.32 (m, 4H), 
7.09 (dt, J = 8.1, 1.1 Hz, 1H), 6.44 (dd, J = 3.7, 0.8 Hz, 1H), 4.19 (dt, J = 10.9, 8.6 Hz, 1H), 3.44 
(dd, J = 8.7, 2.9 Hz, 1H), 2.85 (t, J = 10.7 Hz, 1H), 2.25 (ddd, J = 10.3, 8.6, 3.0 Hz, 1H), 1.61 (s, 
9H), 1.54 (s, 3H), 1.23 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.6, 150.0, 147.9, 138.6, 138.4, 136.3, 135.5, 134.7, 128.7, 
127.9, 127.5, 125.3, 121.6, 121.5, 121.1, 120.5, 116.5, 113.4, 107.4, 83.4, 57.9, 38.2, 36.4, 35.9, 
30.2, 28.3, 25.3. 
FTIR (NaCl, thin film, cm-1): 3358, 3008, 2954, 2929, 2866, 1730, 1686, 1618, 1578, 1523, 1485, 
1424, 1386, 1370, 1338, 1253, 1214, 1151, 117, 1077, 1022, 826, 816, 756. 
HRMS (ESI-TOF, m/z): calc’d for C29H32N3O3 [M+H]+: 470.2438; found: 470.2449. 
9o 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 4-
(5-iodopyrin-2-yl)piperazine-1-carboxylic acid tert-butyl ester (2 
equiv, 156 mg, 0.4 mmol). The crude residue was purified by column 
chromatography using silica gel basified with 5 mL of aqueous 
ammonium hydroxide (20% EtOAc/2% Et3N/78% hexanes → 30% 
EtOAc/2% Et3N/68% hexanes → 40% EtOAc/2% Et3N/58% 
hexanes) to give a pale, yellow foam. 
Run 1: (79.9 mg, 77%), Run 2: (84.6 mg, 82%) 
Rf = 0.27 (silica gel, 40% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = +69.2° (c = 5.1, CHCl3). 
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1H NMR (500 MHz, CDCl3): δ 9.58 (s, 1H), 8.74 (dd, J = 4.2, 1.7 Hz, 1H), 8.62 (p, J = 4.4 Hz, 
1H), 8.10 (dd, J = 8.2, 1.7 Hz, 1H), 8.06 (dt, J = 2.5, 0.8 Hz, 1H), 7.50 (ddd, J = 8.7, 2.5, 0.7 Hz, 
1H), 7.46 – 7.37 (m, 3H), 6.53 (dd, J = 8.8, 0.8 Hz, 1H), 3.93 (dt, J = 11.0, 8.6 Hz, 1H), 3.45 (dd, 
J = 6.6, 3.5 Hz, 4H), 3.39 (dd, J = 6.3, 3.6 Hz, 4H), 3.30 (dd, J = 8.4, 2.9 Hz, 1H), 2.74 (t, J = 10.8 
Hz, 1H), 2.10 (ddd, J = 10.4, 8.5, 2.9 Hz, 1H), 1.51 (s, 4H), 1.47 (s, 9H), 1.24 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.4, 158.0, 154.9, 148.0, 146.8, 138.4, 137.0, 136.4, 134.5, 
127.9, 127.4, 126.4, 121.6, 121.2, 116.4, 106.9, 79.9, 57.7, 45.5, 37.6, 35.9, 33.5, 30.1, 28.5, 25.1. 
FTIR (NaCl, thin film, cm-1): 3357, 3007, 2973, 2928, 2864, 2360, 1686, 1605, 1560, 1524, 1486, 
1424, 1391, 1324, 1241, 1166, 1129, 1084, 1000, 934, 864, 826, 792, 756, 686, 666. 
HRMS (ESI-TOF, m/z): calc’d for C30H38N5O3 [M+H]+: 516.2969; found: 516.2955. 
9p 
Prepared from cyclobutamide 4 (1 equiv, 50.8 mg, 0.2 mmol) and 5-
iodo-2-(1-piperidinyl)pyrimidine (2 equiv, 116 mg, 0.4 mmol). The 
crude residue was purified by column chromatography using silica gel 
basified with 5 mL of aqueous ammonium hydroxide (10% EtOAc/2% 
Et3N/88% hexanes → 20% EtOAc/2% Et3N/78% hexanes → 30% 
EtOAc/2% Et3N/68% hexanes) to give a pale yellow foam. 
Run 1: (63.0 mg, 76%), Run 2: (60.6 mg, 73%) 
Rf = 0.44 (silica gel, 40% EtOAc/Hex, UV). 
[α]D25 = +83.3° (c = 3.1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 9.59 (s, 1H), 8.74 (dd, J = 4.2, 1.7 Hz, 1H), 8.67 (dd, J = 6.6, 2.4 
Hz, 1H), 8.25 (s, 2H), 8.10 (dd, J = 8.2, 1.7 Hz, 1H), 7.47 – 7.42 (m, 2H), 7.40 (dd, J = 8.2, 4.2 
Hz, 2H), 3.81 (dt, J = 11.0, 8.6 Hz, 1H), 3.67 (dd, J = 6.2, 4.9 Hz, 4H), 3.27 (dd, J = 8.6, 2.9 Hz, 
1H), 2.74 (t, J = 10.8 Hz, 1H), 2.07 (ddd, J = 10.6, 8.5, 2.9 Hz, 1H), 1.60 (p, J = 5.5 Hz, 2H), 1.52 
(qd, J = 5.6, 5.1, 2.3 Hz, 4H), 1.49 (s, 3H), 1.24 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.2, 160.8, 157.1, 148.1, 138.4, 136.4, 134.5, 127.9, 127.5, 
121.6, 121.3, 120.8, 116.5, 57.4, 45.0, 37.3, 36.1, 31.8, 30.0, 25.8, 25.1, 25.0. 
FTIR (NaCl, thin film, cm-1): 3355, 2031, 2853, 1682, 1603, 1524, 1485, 1462, 1447, 1366, 1324, 
1274, 1256, 1160, 1025, 946, 826, 792, 754. 
HRMS (ESI-TOF, m/z): calc’d for C25H30N5O [M+H]+: 416.2445; found: 416.2440. 
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Proof of Enantiopurity 
9m, racemic sample. Chiral SFC: (OD-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 nm): tR(minor) 
= 9.7 min, tR(major) = 11.1 min. 
 
 
9m, enantioenriched sample. Chiral SFC: (OD-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 nm): 
tR(minor) = 9.7 min, tR(major) = 11.1 min. 
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3. Carboxylic Acid Derivatization 
Large-scale synthesis of 9d  
 
A 48 mL pressure flask was charged with cyclobutamide 4 (608 mg, 2.39 mmol, 1.00 
equiv), Ag2CO3 (659 mg, 2.39 mmol, 1.00 equiv), and Pd(OAc)2 (80.5 mg, 0.358 mmol, 15 mol%) 
followed by 4-iodotoluene (1.04 g, 4.78 mmol, 2.00 equiv). The solids were suspended in TBME 
(12 mL, 0.2 M). The vessel was sealed, placed in a pre-heated oil bath (90 ºC), and allowed to stir 
for 18 h. The reaction mixture was cooled to room temperature, diluted with CH2Cl2, and filtered 
through a 40 g celite plug with approx. 150 mL CH2Cl2. The solvent was removed in vacuo, and 
the crude oil was purified by silica gel flash chromatography (10 → 15% EtOAc/hexanes) to afford 
9d as a white solid (700. mg, 85% yield). 
Hydrolysis: preparation of 101 
 
A 48 mL pressure flask was charged with cis-cyclobutamide 9d (693 mg, 2.01 mmol, 1.00 equiv), 
sodium hydroxide (1.21 g, 30.2 mmol, 15 equiv), and absolute ethanol (8.5 mL, 0.24 M). The flask 
was sealed and placed in a pre-heated oil bath (130 ºC) and stirred for 18 h. The reaction mixture 
was cooled to room temperature, and the solvent was removed in vacuo. The crude residue was 
diluted with 1 M aq HCl (38 mL) and EtOAc (38 mL). The organic and aqueous layers were 
separated, and the organic layer was washed with 1 M HCl (2 x 38 mL). The organic layer was 
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dried over MgSO4, filtered, and concentrated in vacuo. The crude reddish solid was purified by 
silica gel flash chromatography (15 → 20% EtOAc/hexanes) to afford 10 as an off-white solid 
(443 mg, >99% yield).  
 
Rf = 0.31 (silica gel, 20% EtOAc/Hexanes, p-anisaldehyde) 
[α]D25 = +123.6° (c = 0.28, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.13 (d, J = 1.1 Hz, 4H), 3.74 (q, J = 9.8 Hz, 1H), 2.91 (dd, J = 
10.0, 0.8 Hz, 1H), 2.32 (s, 3H), 2.11 (ddd, J = 10.9, 8.9, 0.9 Hz, 1H), 1.95 (t, J = 10.5 Hz, 1H), 
1.29 (s, 3H), 1.25 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 178.8, 140.7, 135.9, 129.2, 126.6, 55.2, 39.4, 36.6, 35.1, 30.6, 
23.6, 21.2. 
FTIR (NaCl, thin film, cm-1): 3021, 2957, 2927, 2867, 2731, 2647,1699, 1516, 1464, 1421 1370, 
1281, 1238, 1162 1118, 937, 806, 716. 
HRMS (ESI-TOF, m/z): calc’d for C14H22NO2 [M+NH4]+: 236.1645; found: 236.1645. 
 
Reduction to form alcohol 12 
 
A 2-dram vial containing a stir bar was charged with 10 (87 mg, 0.400 mmol, 1.00 equiv) 
and NaBH4 (37.8 mg, 1.00 mmol, 2.5 equiv). The vial was then evacuated and backfilled with N2 
three times. THF (3.0 mL) was added and the reaction mixture was cooled to 0 °C. I2 (121.8 mg, 
0.480 mmol, 1.2 equiv) was then added as a solution in THF (1 mL) dropwise. The vial was then 
sealed with a Teflon-lined cap, placed in a pre-heated oil bath (70 ºC), and allowed to stir 
overnight. Once the reaction was complete, the reaction was cooled to room temperature and 
quenched with MeOH until bubbling stopped and the reaction mixture turned clear. The reaction 
mixture was then concentrated, then treated with 20% KOH (4 mL) and allowed to stir for 5 h at 
room temperature. The aqueous layer was then extracted with EtOAc (6 x 5 mL). The combined 
Me
Me OHNaBH4, I2
THF, 0 °C to 70 °C
(81% yield)
12 Me
Me
Me
O
OH
10 Me
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organic layers were dried over Na2SO4 and concentrated to afford 12 (82.2 mg, quant yield) as a 
white solid which was carried forward without further purification.  
Rf = 0.38 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +57.0° (c = 0.42, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.18 – 7.08 (m, 4H), 3.75 (qd, J = 11.0, 7.2 Hz, 2H), 3.06 (q, J = 
9.5 Hz, 1H), 2.34 (s, 3H), 2.28 (dddd, J = 9.4, 8.3, 6.1, 0.7 Hz, 1H), 2.05 (ddd, J = 10.8, 8.7, 0.8 
Hz, 1H), 1.82 (t, J = 10.3 Hz, 1H), 1.21 (s, 6H). 
13C NMR (101 MHz, CDCl3): δ 141.9, 135.6, 129.1, 126.7, 63.6, 53.9, 40.6, 37.6, 33.7, 31.4, 
22.5, 21.1. 
FTIR (NaCl, thin film, cm-1): 3248, 2954, 2926, 2896, 2864, 1896, 1514, 1453, 1413, 1379, 1368, 
1326, 1260, 1218, 1190, 1110, 1092, 1033, 1013, 812, 772. 
HRMS (ESI-TOF, m/z): calc’d for C14H24NO [M+NH4]+: 222.1852; found: 222.1846.  
Stahl oxidation to form aldehyde 132 
 
 12 (0.400 mmol, 1.00 equiv) was dissolved in 1.2 mL MeCN in a 20 mL scintillation vial. 
In a separate vial Cu(MeCN)4OTf (7.5 mg, 0.02 mmol, 0.05 equiv) and 4,4’-MeObpy (4.3 mg, 
0.02 mmol, 0.05 equiv)) were dissolved in 0.4 mL MeCN and allowed to stir until the solution 
turned an opaque blue. To this vial was added a solution of ABNO (0.6 mg, 0.004 mmol, 0.01 
equiv) and N-methylimidazole (3.3 mg, 0.04 mmol, 0.10 equiv) in 0.4 mL MeCN. Once the 
catalyst solution turned green, it was added to the reaction mixuture and allowed to stir open to 
air. After 3 h and 6 h, additional portions of catalyst (Cu(MeCN)4OTf (7.5 mg, 0.02 mmol, 0.05 
equiv), 4,4’-MeObpy (4.3 mg, 0.02 mmol, 0.05 equiv) ABNO (0.6 mg, 0.004 mmol, 0.01 equiv), 
and N-methylimidazole (3.3 mg, 0.04 mmol, 0.10 equiv) dissolved in 0.8 mL MeCN) were added. 
After the addition at 6 h, the reaction vessel was sealed with a rubber septum and the reaction 
mixture was sparged with O2(g) and allowed to stir under an O2 atmosphere for an additional 15.5 
h. When the reaction was judged to be done by TLC, the reaction mixture was filtered over a short 
Me
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12 Me
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silica plug, eluting with 20% EtOAc/hexanes, and the resulting solution was concentrated in vacuo 
to give 13 as a brown oil (71.1 mg, 87% yield). 
Rf = 0.69 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
 [α]D25 = +62.9° (c = 1.66, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 9.86 (d, J = 1.6 Hz, 1H), 7.21 – 7.01 (m, 5H), 3.88 (q, J = 9.6 Hz, 
1H), 2.97 (ddd, J = 9.7, 1.7, 0.9 Hz, 1H), 2.34 (s, 3H), 2.12 (ddt, J = 10.5, 8.9, 0.8 Hz, 1H), 2.02 
(t, J = 10.5 Hz, 1H), 1.36 (s, 3H), 1.26 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 203.0, 140.8, 135.8, 129.1, 129.1, 126.5, 126.5, 62.5, 39.9, 37.5, 
33.0, 31.3, 24.0, 23.6, 21.1, 21.1. 
FTIR (NaCl, thin film, cm-1): 3248, 2954, 2926, 2896, 2864, 1896, 1514, 1453, 1413, 1379, 1368, 
1326, 1260, 1218, 1190, 1110, 1092, 1033, 1013, 812, 772. 
HRMS (ESI-TOF, m/z): calc’d for C14H22NO [M+NH4]+: 220.1696; found: 220.1691.  
 
Acid chloride formation and Suzuki coupling: preparation of ketone 143 
 
 A 1-dram vial containing a stir bar was charged with carboxylic acid 10 (87.3 mg, 0.400 
mmol, 1 equiv). The vial was sealed with a septum vial cap and tape and was evacuated and 
backfilled with N2 three times. CH2Cl2 (0.8 mL, 0.5 M) and 1-2 drops DMF were added, and the 
reaction mixture was cooled to 0 °C. Oxalyl chloride (0.050 mL, 0.560 mmol, 1.4 equiv) was then 
added dropwise. Once the addition was complete, the reaction was allowed to stir at room 
temperature for 1 h, at which point the solvent was removed in vacuo to afford acid chloride SI-1 
as a crude oil. SI-1 was taken forward without further purification.   
1H NMR (400 MHz, CDCl3): δ 7.16 – 7.06 (m, 4H), 3.79 (q, J = 9.7 Hz, 1H), 3.29 (dd, J = 9.8, 
0.9 Hz, 1H), 2.33 (s, 3H), 2.11 (ddd, J = 10.9, 9.1, 1.0 Hz, 1H), 2.01 – 1.88 (m, 1H), 1.41 (s, 3H), 
1.31 (s, 3H). 
Me
Me OH
O
Me10
Me
Me Cl
O
MeSI-1
Me
Me
O
Me14
oxalyl chloride
DMF (cat)
CH2Cl2
0 °C to 23 °C
NiCl2•dme (5 mol %)
dtbbpy (5.5 mol %)
Mnº (3.00 equiv) 
DMA,0 °C, 16 h
(74% yield over 2 steps)
I
(1.50 equiv)
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13C NMR (101 MHz, CDCl3): δ 173.3, 139.2, 136.5, 129.4, 126.5, 66.1, 39.0, 37.0, 30.0, 23.2, 
21.2.   
A flame-dried 1-dram vial containing a 2-dram stir bar (tested before to ensure it would 
stir) was charged with NiCl2•dme (4.4 mg, 0.020 mmol, 0.05 equiv), dtbbpy (5.9 mg, 0.022 mmol, 
0.055 equiv), and Mn° powder (65.9 mg, 1.20 mmol, 3.00 equiv). The vial was sealed with a septa 
and tape and evacuated and backfilled with N2 three times. 0.6 mL DMA was then added, and the 
reaction mixture was stirred vigorously (~1300 rpm) for about 30 min. The mixture should be a 
dark black color. The reaction mixture was then cooled to 0 °C in an ice bath. Iodocyclohexane 
(0.078 mL, 0.600 mmol, 1.50 equiv) was then added, followed by freshly prepared acid chloride 
SI-1 (94.7 mg, 0.400 mmol, 1.0 equiv) dissolved in 0.8 mL DMA. The sealed vial was then placed 
in a cryocool set to 0 °C and allowed to stir for 16 h. The reaction mixture was then quenched with 
1.0 mL H2O and extracted with CH2Cl2 (4 x 2.0 mL). The combined organic layers were filtered 
through a Na2SO4 plug and concentrated in vacuo. The resulting crude oil was purified by silica 
gel flash chromatography (0 → 5% EtOAc/hexanes) to afford 14 as a pale yellow, clear oil (84.6 
mg, 74% yield over 2 steps).  
Rf = 0.76 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +17.1° (c = 2.247, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.11 – 7.05 (m, 2H), 7.02 (d, J = 8.0 Hz, 2H), 3.85 (q, J = 9.6 Hz, 
1H), 3.13 (dd, J = 9.6, 0.8 Hz, 1H), 2.31 (s, 3H), 2.21 (tt, J = 11.3, 3.3 Hz, 1H), 2.02 (ddd, J = 
10.6, 8.8, 0.8 Hz, 1H), 1.92 (t, J = 10.5 Hz, 1H), 1.88 – 1.62 (m, 3H), 1.44 (tdd, J = 13.0, 11.4, 3.6 
Hz, 1H), 1.34 (s, 3H), 1.31 – 1.11 (m, 4H), 1.06 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 212.7, 141.7, 135.5, 129.1, 126.5, 60.9, 50.8, 39.1, 37.4, 33.2, 
31.3, 29.6, 26.9, 26.3, 26.0, 25.5, 24.0, 21.1. 
FTIR (NaCl, thin film, cm-1):  3380, 3048, 3020, 2929, 2855, 1894, 1698, 1515, 1449, 1370, 
1331, 1288, 1244, 1183, 1145, 1066, 1021m 994, 952, 892, 829, 805, 759. 
HRMS (ESI-TOF, m/z): calc’d for C20H32NO [M+NH4]+: 302.2478; found: 302.2470.  
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Preparation of NHP ester 11 
 
A 20 mL vial was charged with carboxylic acid 10 (208.9 mg, 0.957 mmol, 1.00 equiv), 
N-hydroxyphthalimide (156.1 mg, 0.957 mmol, 1.00 equiv), and 4-dimethylaminopyridine (11.7 
mg, 0.096 mmol, 0.10 equiv). The vial was sealed with a rubber septum and evacuated and 
backfilled with N2 three times. The solids were dissolved in CH2Cl2 (4 mL), and then EDC (201.8 
mg, 1.05 mmol, 1.10 equiv) was added as a slurry in CH2Cl2 (1.3 mL). The reaction mixture was 
allowed to stir for 23 hours at room temperature. The reaction mixture was then transferred to a 
flask containing EtOAc (50 mL), and the resulting solids were removed by filtration. The filtrate 
was concentrated in vacuo and the crude oil was purified by silica gel flash chromatography (15 
→ 40% EtOAc/hexanes) to afford 11 as a white solid (272.8 mg, 78% yield).  
Rf = 0.46 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +100.5° (c = 0.42, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.94 – 7.83 (m, 2H), 7.83 – 7.73 (m, 2H), 7.14 (s, 4H), 3.87 (q, J 
= 9.8 Hz, 1H), 3.21 (dd, J = 9.9, 0.9 Hz, 1H), 2.33 (s, 3H), 2.20 (ddd, J = 10.8, 8.9, 0.9 Hz, 1H), 
2.08 (t, J = 10.5 Hz, 1H), 1.42 (s, 3H), 1.39 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 168.9, 162.2, 139.7, 136.3, 134.8, 129.3, 129.1, 126.5, 124.0, 
52.5, 39.6, 37.5, 35.3, 30.5, 23.7, 21.2. 
FTIR (NaCl, thin film, cm-1): 3520, 3022, 2959, 2927, 2868, 1808, 1794, 1745, 1615, 1516, 1467, 
1368, 1274, 1186, 1132, 1081, 1016, 972, 878, 811, 786, 696.  
HRMS (ESI-TOF, m/z): calc’d for C22H21NO4 [M+NH4]+: 381.1809; found: 381.1814.  
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Negishi coupling to form diaryl cyclobutane 164 
 
A 25 mL round bottom flask was charged with 11 (109 mg, 0.300 mmol, 1.00 equiv), 
NiCl2•dme (13.2 mg, 0.060 mmol, 0.20 equiv), and dtbbpy (32.2 mg, 0.120 mmol, 0.40 equiv). 
The flask was sealed with a septum and then evacuated and backfilled with argon three times. 
DMF was then added (3.2 mL), forming a green solution. Freshly prepared aryl zinc reagent 15 
(4.8 mL, 0.90 mmol, 3.0 equiv, 0.19 M in THF) was then added and the solution turned red. The 
reaction was allowed to stir for 18 h, at which point the reaction was quenched with 1 M HCl (10 
mL) and diluted with EtOAc (10 mL). The organic and aqueous layers were separated, and the 
organic layer was washed with water (10 mL) and brine (10 mL). The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to afford a red oil. The crude material was then purified 
by silica gel flash chromatography (2.5 → 25% PhMe/hexanes) to afford 16 as a clear oil (63 mg, 
75% yield).  
Rf = 0.77 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +195° (c = 0.42, CHCl3).  
1H NMR (500 MHz, CDCl3): δ 7.26 – 7.17 (m, 1H), 7.14 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 7.9 Hz, 
2H), 6.81 (ddt, J = 7.6, 1.7, 0.9 Hz, 1H), 6.80 – 6.71 (m, 2H), 3.79 (s, 3H), 3.32 (d, J = 10.4 Hz, 
1H), 2.30 (s, 3H), 2.16 (ddd, J = 10.3, 8.5, 0.7 Hz, 1H), 1.90 (t, J = 10.1 Hz, 1H), 1.28 (s, 3H), 
0.88 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 159.6, 142.8, 142.1, 135.5, 129.1, 129.0, 126.6, 120.0, 113.6, 
111.0, 56.7, 55.2, 40.2, 37.4, 37.2, 30.9, 23.3, 21.1. 
FTIR (NaCl, thin film, cm-1): 3014, 2947, 2859, 1596, 1514, 1490, 1458, 1428, 1371, 1318, 1292, 
1252, 1166, 1040, 832, 808, 797, 694.  
HRMS (ESI-TOF, m/z): calc’d for C15H25O3 [M+H]+: 281.1900; found: 281.1899.  
Me
Me
Me
OMe
Me
Me
O
Me
O N
O
O
NiCl2•dme (20%)
dtbbpy (40%)
DMF/THF (2:3), rt
MeO ZnCl•LiCl
3 equiv
(75% yield)11 16
15
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Reductive coupling of NHP ester 11 and vinyl bromide 17: preparation of 185 
 
 A 1-dram vial containing a 2-dram stir bar was charged with NHP ester 11 (75.7 mg, 0.208 
mmol, 1.00 equiv) and vinyl bromide 17 (63.9 mg, 0.300 mmol, 1.50 equiv). A separate ½-dram 
vial containing a stir bar was charged with dtbbpy (5.4 mg, 0.020 mmol, 0.10 equiv). Both vials 
were brought into a N2 filled glovebox. The vial containing dtbbpy was charged with NiBr2•dme 
(6.2 mg, 0.020 mmol, 0.10 equiv) and DMA (0.200 mL, 1.0 M) and allowed to stir for 10 minutes. 
The vial containing 11 and 17 was charged with Zn powder (25.4 mg, 0.400 mmol, 2.00 equiv). 
Once the catalyst solution prestir was complete, the catalyst solution was added to the reaction vial 
via pipette. The vial was then sealed with a Teflon-lined cap, removed from the glovebox, placed 
in a pre-heated oil bath (28 °C), and allowed to stir for 15 h. Once the reaction was complete, the 
reaction mixture was diluted with Et2O and passed through a short silica plug, eluting with Et2O. 
The material was concentrated onto celite in vacuo, and the resulting powder was purified by silica 
gel flash chromatography (0 → 30% PhMe/hexanes) to afford 18 as a white solid (34.1 mg, 56% 
yield). 
Rf = 0.71 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +238° (c = 1.66, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.28 (m, 2H), 7.15 (d, J = 8.1 Hz, 2H), 7.11 (d, J = 8.0 Hz, 
2H), 6.89 – 6.83 (m, 2H), 6.34 (d, J = 15.8 Hz, 1H), 6.22 (dd, J = 15.8, 7.8 Hz, 1H), 3.81 (s, 3H), 
3.41 (q, J = 9.5 Hz, 1H), 2.73 (ddt, J = 9.5, 7.7, 0.9 Hz, 1H), 2.33 (s, 3H), 2.11 (ddd, J = 10.7, 8.5, 
0.8 Hz, 1H), 1.87 (t, J = 10.3 Hz, 1H), 1.18 (s, 3H), 1.16 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 158.9, 142.3, 135.3, 130.7, 130.0, 129.0, 128.1, 127.3, 126.6, 
114.0, 55.9, 55.4, 40.0, 39.6, 36.9, 30.4, 23.6, 21.2.  
Me
Me
O
Me
O N
O
O
Me
Me
Me
Zn, DMA
MeO
Br
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2 equiv
NiBr2•dme (10%)
 dtbbpy (10%)
11 18
(56% yield)
17
     S25 
FTIR (NaCl, thin film, cm-1): 2999, 2951, 2921, 2860, 1607, 1511, 1462, 1370, 1249, 1174, 1106, 
1036, 966, 806. 
HRMS (ESI-TOF, m/z): calc’d for C22H27O [M+H]+: 307.2056; found: 307.2062.  
 
Decarboxylative quinolinylation: preparation of 196 
 
 A flame-dried 20dram vial was charged with NHP ester 11 (72.7, mg, 0.200 mmol, 1.00 
equiv) and Ir[dF(CF3)ppy]2(dtbbpy)PF6 (4.5 mg, 0.004 mmol, 0.02 equiv). The vial was evacuated 
and backfilled with Ar three times.  DMA (2.0 mL, 0.1 M) and lepidine (43.0 mg, 0.300 mmol, 
1.50 equiv) were then added, and the reaction mixture was cooled to 0 °C and sparged with Ar 10 
minutes. The reaction vial was removed from the ice bath, trifluoroacetic acid (30.6 µL, 0.400 
mmol, 2.00 equiv) was added, and the reaction mixture was allowed to stir in front of a 34W blue 
LED lamp (~3 cm from the lamp). The reaction was monitored by TLC (20% EtOAc/hexanes). 
Once the reaction was complete (~4 h), the reaction was quenched with 1 mL NEt3 and 2 mL H2O. 
The aqueous layer was extracted with EtOAc (3 mL x 4), and the combined organics were washed 
with 1 M LiCl. The organic layer was then dried with Na2SO4, filtered, and concentrated onto 
celite in vacuo, and the resulting powder was purified by silica gel flash chromatography (0 → 5% 
EtOAc/hexanes) to afford 19 as a yellow solid (34.1 mg, 54% yield). 
Rf = 0.76 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +305° (c = 1.47, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 8.09 (d, J = 8.4 Hz, 1H), 7.95 (dd, J = 8.3, 1.4 Hz, 1H), 7.67 (ddd, 
J = 8.3, 6.7, 1.4 Hz, 1H), 7.50 (ddd, J = 8.1, 6.8, 1.3 Hz, 1H), 7.21 (d, J = 7.9 Hz, 2H), 7.08 (d, J 
= 8.1 Hz, 3H), 4.39 (q, J = 9.7 Hz, 1H), 3.52 (d, J = 10.1 Hz, 1H), 2.67 (s, 3H), 2.30 (s, 3H), 2.20 
(dd, J = 10.4, 8.8 Hz, 1H), 2.04 (t, J = 10.3 Hz, 1H), 1.39 (s, 3H), 0.89 (s, 3H). 
Me
Me
O
O
O
O
N [Ir] (2%), TFA (2 equiv)
DMA, blue LEDs
N
Me
Me
Me N
Me
Me Me
11 19
(54% yield)
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13C NMR (101 MHz, CDCl3): δ 13C NMR (101 MHz, CDCl3) δ 160.6, 148.0, 143.4, 142.6, 135.2, 
130.2, 129.0, 128.9, 128.8, 128.7, 127.1, 126.9, 126.8, 125.4, 123.7, 121.7, 59.1, 39.7, 37.9, 35.4, 
31.2, 23.7, 21.1, 18.9. 
FTIR (NaCl, thin film, cm-1): 3428, 3950, 2925, 2360, 1603, 1558, 1514, 1446, 1379, 1260, 1176, 
1162, 1034, 809, 756. 
HRMS (ESI-TOF, m/z): calc’d for C23H26N [M+H]+: 316.2060; found: 316.2063.  
 
Decarboxylative borylation of NHP ester 11 to form borylate 207 
 
 A flame-dried 2-dram vial was charged with NHP ester 11 (72.7, mg, 0.200 mmol, 1.00 
equiv) and B2cat2 (59.5 mg, 0.250 mmol, 1.25 equiv). The vial was evacuated and backfilled with 
Ar three times.  DMA (2.0 mL, 0.1 M) was then added, and the reaction mixture was cooled to 0 
°C and sparged with Ar for 10 minutes. The reaction vial was removed from the ice bath and 
suspended inside a large beaker lined with 12W blue LED strips and covered with foil. After 21 
h, pinacol (94.5 mg, 0.800 mmol, 4.00 equiv) was added as a solution in NEt3 (700 µL, 5.04 mmol, 
25.2 equiv). After 2 h, the reaction was quenched with H2O, saturated aqueous NH4Cl, and EtOAc. 
The organic and aqueous layers were separated, and the aqueous layer was extracted with EtOAc 
(2 mL x 3). The combined organics were then dried with Na2SO4, filtered, and concentrated onto 
celite in vacuo, and the resulting powder was purified by silica gel flash chromatography (0 → 5% 
EtOAc/hexanes) to afford 20 as a white solid (35.1 mg, 58% yield). 
Rf = 0.81 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +77.5° (c = 1.47, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.09 (s, 4H), 3.53 (td, J = 10.2, 8.2 Hz, 1H), 2.31 (s, 3H), 2.13 
(ddd, J = 10.6, 8.2, 0.8 Hz, 1H), 2.02 (t, J = 10.3 Hz, 1H), 1.68 (d, J = 10.5 Hz, 1H), 1.26 (s, 6H), 
1.24 (d, J = 1.1 Hz, 9H), 1.16 (s, 3H). 
Me
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13C NMR (101 MHz, CDCl3): δ 144.1, 134.9, 128.9, 126.3, 83.2, 42.9, 34.3, 34.0, 32.4, 26.6, 
25.3, 24.9, 21.1. (Note: the resonance from the carbon attached to the boron was not visible).  
FTIR (NaCl, thin film, cm-1): 3444, 2980, 2922, 2946, 2862, 2728, 1898, 1652, 1514, 1462, 1414, 
1380, 1363, 1345, 1329, 1275, 1237, 1143, 1112, 1080, 1020, 967, 854, 809, 730. 
HRMS (ESI-TOF, m/z): calc’d for C19H29BO2Na [M+Na]+: 323.2158; found: 323.2174.  
 
4. Synthesis of (+)-rumphellaone A 
Large-Scale C-H Activation Procedure for the Preparation of 24 
 
 A 48 mL pressure flask was charged with cyclobutamide 4 (400 mg, 1.57 mmol, 1.00 
equiv), Ag2CO3 (434 mg, 1.57 mmol, 1.00 equiv), and Pd(OAc)2 (26.5 mg, 0.118 mmol, 7.5 mol 
%) followed by TMS-iodofuran 23 (834 mg, 3.15 mmol, 2.00 equiv). The mixture was then 
suspended in TBME (8.0 mL, 0.2 M). The vessel was sealed under ambient conditions and placed 
in a pre-heated oil bath (70 ºC). After about 10 minutes, the olive-green mixture becomes black, 
and the reaction mixture is stirred for an additional 18 h. The reaction mixture was then 
concentrated, diluted with toluene (3 mL), and loaded directly onto a silica gel column (0 → 20% 
EtOAc/hexanes) to afford 24 as a clear yellow oil (556 mg, 90% yield). 
Rf = 0.56 (silica gel, 20% EtOAc/Hex, UV, p-anisaldehyde). 
[α]D25 = –57.2° (c = 1.22, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 9.61 (s, 1H), 8.77 (dd, J = 4.2, 1.7 Hz, 1H), 8.68 (dd, J = 6.7, 2.3 
Hz, 1H), 8.11 (dd, J = 8.2, 1.7 Hz, 1H), 7.48 – 7.39 (m, 3H), 6.48 (d, J = 3.1 Hz, 1H), 6.23 (dd, J 
= 3.2, 1.1 Hz, 1H), 4.07 – 3.94 (m, 1H), 3.34 (ddd, J = 9.0, 2.2, 0.8 Hz, 1H), 2.61 – 2.50 (m, 1H), 
2.19 (ddd, J = 11.0, 8.9, 2.3 Hz, 1H), 1.45 (s, 3H), 1.32 (s, 3H), -0.08 (s, 9H).  
Me
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13C NMR (101 MHz, CDCl3): δ 170.1, 160.1, 158.7, 148.0, 138.5, 136.3, 134.8, 127.9, 127.6, 
127.5, 121.5, 121.2, 121.1, 120.5, 120.5, 116.5, 106.8, 55.8, 38.1, 36.6, 32.3, 30.9, 30.7, 30.7, 24.9, 
–1.8. 
FTIR (NaCl, thin film, cm-1): 3360, 3109, 3049, 2954, 2866, 2613, 1944, 1878, 1687, 1595, 1578, 
1522, 1485, 1424, 1385, 1324, 1249, 1161, 1131, 1009, 924, 842, 791, 757. 
HRMS (ESI-TOF, m/z): calc’d for C23H29N2O2Si [M+H]+: 392.1993; found: 393.1990. 
 
Hydrolysis: Preparation of 221 
 
 A 15 mL pressure flask was charged with cis-cyclobutamide 24 (532 mg, 1.36 mmol, 1.00 
equiv), sodium hydroxide (813 mg, 20.33 mmol, 15 equiv), and absolute ethanol (5.7 mL, 0.24 
M). The flask was sealed and placed in a pre-heated oil bath (130 ºC) and stirred for 18 h. The 
solvent was then concentrated in vacuo, and the crude residue was diluted with 1 M HCl (20 mL) 
and EtOAc (20 mL). The organic layer was separated and washed with 1 M HCl (2 x 20 mL). At 
this point, the aqueous layers should be yellow, and the organic layer should be faint brown. The 
combined aqueous layers were extracted with EtOAc (25 mL), and the second organic layer was 
washed with 1 M HCl (25 mL) until it was free of 8-aminoquinoline as indicated by TLC (usually 
1-2 times). The organic layers were combined, dried over MgSO4, filtered, and concentrated in 
vacuo. The crude reddish solid was purified by silica gel flash chromatography (20 → 40 % 
EtOAc/hexanes) to afford 22 as an off-white solid (250 mg, 96 % yield). 
Rf = 0.5 (silica gel, 30% EtOAc/Hex, p-anisaldehyde). 
[α]D25 = +133.0° (c = 0.85, CHCl3).  
1H NMR (400 MHz, CHCl3): δ 7.32 (dd, J = 1.9, 0.9 Hz, 1H), 6.28 (dd, J = 3.2, 1.8 Hz, 1H), 6.05 
(dt, J = 3.2, 0.8 Hz, 1H), 3.72 (q, J = 9.5 Hz, 1H), 3.11 – 3.02 (m, 1H), 2.12 – 1.95 (m, 2H), 1.30 
(s, 3H), 1.19 (s, 3H). 
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 13C NMR (101 MHz, CDCl3): δ 178.3, 156.6, 141.5, 110.3, 105.0, 53.2, 38.3, 36.8, 30.4, 29.2, 
23.4.  
FTIR (NaCl, thin film, cm-1): 3119, 2993, 2956, 2869, 1722, 1682, 1604, 1506, 1461, 1411, 1390, 
1371, 1276, 1224, 1208, 1175, 1161, 1104, 1067, 1008, 946, 918, 884, 850, 804, 743, 730, 695. 
HRMS (ESI-TOF, m/z): calc’d for C11H15O3 [M+H]+: 195.1016; found: 195.1019. 
 
Decarboxylative Michael addition: preparation of methyl ketone 258 
 
 A 100 mL flame-dried round bottom flask was charged with carboxylic acid 22 (342 mg, 
1.76 mmol, 1.00 equiv), Ir[dF(CF3)ppy]2(dtbbpy)PF6 (19.7 mg, 0.0176 mmol, 0.01 equiv), and 
K2HPO4 (368 mg, 1.76 mmol, 1.00 equiv). The flask was evacuated and backfilled with N2 three 
times.  DMF (17.6 mL, 0.1 M) and freshly distilled methyl vinyl ketone (144 µL, 1.76 mmol, 1. 
equiv) were then added, and the reaction mixture was sparged with Ar for 5 minutes. The reaction 
flask was placed about 5 cm from a 34W blue LED lamp and was allowed to stir at room 
temperature under N2. After 42 h, the reaction was quenched with sat aq NaHCO3 and extracted 
with EtOAc (75 mL x 3). The combined organics were then dried with MgSO4, filtered, and 
concentrated in vacuo to afford the product as a crude oil, which was then purified by silica gel 
flash chromatography (3 → 10% EtOAc/hexanes) to afford 25 as a white solid (201 mg, 52% 
yield). 
Rf = 0.79 (silica gel, 20% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +57.8° (c = 1.07, CHCl3).  
1H NMR (400 MHz, CDCl3): δ 7.30 (dd, J = 1.8, 0.9 Hz, 1H), 6.27 (dd, J = 3.1, 1.9 Hz, 1H), 5.97 
(dt, J = 3.2, 0.7 Hz, 1H), 2.97 (td, J = 9.6, 8.5 Hz, 1H), 2.41 – 2.21 (m, 2H), 2.09 – 1.97 (m, 4H), 
1.93 (ddd, J = 10.7, 8.5, 0.7 Hz, 1H), 1.88 – 1.79 (m, 1H), 1.74 – 1.59 (m, 2H), 1.11 (s, 3H), 1.08 
(s, 3H). 
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13C NMR (101 MHz, CDCl3): δ 209.1, 158.9, 140.9, 110.3, 104.0, 50.4, 41.5, 39.0, 34.6, 34.3, 
30.6, 30.1, 24.2, 22.3. 
FTIR (NaCl, thin film, cm-1): 3114, 2953, 2933, 2863, 1717, 1593, 1506, 1451, 1411, 1368, 1360, 
1235, 1159, 1150, 1009, 799, 729. 
HRMS (ESI-TOF, m/z): calc’d for C14H20O2Na [M+Na]+: 243.1356; found: 243.1359.  
 
Preparation of 269 
 
 A 50 mL round bottom flask was charged with carboxylic acid 22 (200 mg, 1.03 mmol, 
1.00 equiv) and was evacuated and backfilled with N2 three times. 5:1 tBuOH/H2O (5.2 mL, 0.2 
M) was added. Once the starting material was fully dissolved, NaH2PO4•H2O (213 mg, 1.54 mmol, 
1.50 equiv) was added in one portion, followed by NaClO2 (349 mg, 3.09 mmol, 3.00 equiv, 80%). 
The suspension turned bright yellow within the first 10-15 minutes. The reaction mixture was 
allowed to stir 2-3 hours, at which point the yellow color dissipated and no more starting material 
was observed by TLC. The reaction mixture was concentrated in vacuo, and the resulting solids 
were solubilized with a mixture of EtOAc and minimal H2O. This crude mixture was concentrated 
onto 4 g SiO2. The powder was applied to a silica gel column and purified by flash silica gel 
chromatography (0 → 5% MeOH/CH2Cl2, followed by flushing with 50% MeOH/CH2Cl2) to 
afford 26 as a white solid (151 mg, 65% yield, 93% pure by QNMR).   
Rf = 0.20 (silica gel, 10% MeOH/CH2Cl2, UV, p-anisaldehyde) 
[α]D25 +62.6° (c = 0.22, MeOH).   
1H NMR (400 MHz, MeOD-d4): δ 7.27 (d, J = 5.9 Hz, 1H), 6.12 (d, J = 5.8 Hz, 1H), 2.92 (q, J = 
9.4 Hz, 1H), 2.72 (d, J = 9.6 Hz, 1H), 1.80 (t, J = 10.3 Hz, 1H), 1.70 (dd, J = 11.0, 9.0 Hz, 1H), 
1.20 (s, 3H), 1.10 (s, 3H). 
13C NMR (101 MHz, MeOD-d4): δ 175.7, 172.9, 155.7, 123.6, 51.5, 49.5, 37.8, 37.1, 36.9, 36.2, 
33.7, 30.4, 30.3, 24.1, 23.7.  
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FTIR (NaCl, thin film, cm-1): 3098, 2960, 2871, 1726, 1416, 1373, 1280, 1255, 1187, 1160, 1114, 
1032, 1007, 935, 852, 829, 713. 
HRMS (ESI-TOF, m/z): calc’d for C11H16O5 [M+H]+: 227.0919; found: 227.0922. 
 
Ti(CH3)4 Conditions for Methylation: Preparation of 28 
 
 A 50 mL round bottom flask was flame-dried under vacuum and then back-filled with N2. 
The flask was charged with CH2Cl2 (5 mL) and cooled to –78 ºC, at which point, TiCl4 (142 µL, 
1.33 mmol, 6.00 equiv) was added. The flask was then charged with MeLi (1.5 M in Et2O; 4.00 
mL, 5.30 mmol, ~24 equiv) dropwise via syringe, until the color of the solution changed from dark 
brown, to bright orange, and finally to dark green. The resulting solution was stirred for 1h at –78 
ºC. A flame-dried 50 mL pear-shaped (pointed) flask was charged with 26 (49.0 mg, 0.217 mmol, 
1.00 equiv) and then evacuated and backfilled with N2 three times. The substrate was dissolved in 
CH2Cl2 (23 mL) and sonicated to dissolve any particulates. The solution was cooled to –78 ºC, 
then added to the reaction flask via a slow cannula transfer. If the addition proceeds too quickly or 
the solution of starting material is not sufficiently cooled, the reaction will favor the undesired 
diastereomer. The flask containing 26 was rinsed with 2 mL CH2Cl2 to complete the transfer. The 
resulting mixture was allowed to stir at –78 ºC. After 4 h the reaction was quenched with 1 M HCl 
(20 mL), allowed to warm to 23 °C, and stirred for 30 minutes during which time the aqueous 
layer became blue/green. The organic and aqueous layers were separated, and the aqueous layer 
was extracted with EtOAc (20 mL x 4), dried over MgSO4, filtered, and concentrated in vacuo. 
The crude residue was purified by silica gel flash chromatography (0 → 10% MeOH/CH2Cl2) to 
afford 28 white solid (29 mg, 9:1 dr, 60% yield)  
Rf = 0.43 (silica gel, 10% MeOH/CH2Cl2, UV, p-anisaldehyde) 
[α]D25 = +43.0° (c = 0.46, CHCl3).   
Me
Me
O
O
OH
26
H
OHO
Me
Me
O
O
OH
28
H
OMe
TiCl4 (6 equiv)
MeLi (24 equiv)
CH2Cl2 (0.0075 M)
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1H NMR (400 MHz, CDCl3): 7.23 (d, J = 5.6 Hz, 1H), 6.01 (d, J = 5.6 Hz, 1H), 3.48 (s, 1H), 2.99 
(dd, J = 9.4, 0.8 Hz, 1H), 2.92 – 2.78 (m, 1H), 1.46 – 1.41 (m, 1H), 1.39 (s, 3H), 1.35 (dd, J = 11.1, 
9.9 Hz, 1H), 1.20 (s, 3H), 1.10 (s, 3H). 
 13C NMR (101 MHz, CDCl3): δ 178.3, 172.9, 172.8, 158.8, 121.1, 88.5, 49.1, 47.1, 36.4, 35.6, 
35.5, 32.1, 29.9, 23.8, 21.7.  
FTIR (NaCl, thin film, cm-1): 3087, 2958, 2869, 1737, 1600, 1463, 1453, 1403, 1380, 1372, 1305, 
1280, 1266, 1218, 1183, 1163, 1136, 1093, 1037, 961, 924, 880, 852, 824, 728, 711, 658. 
HRMS (ESI-TOF, m/z): calc’d for C12H20NO4 [M+NH4]+: 242.1387; found: 242.1394. 
 
(OiPr)3TiCH3 Conditions for Methylation: Preparation of 2610 
 
A flame-dried 50 mL round bottom flask was backfilled with N2 and charged with THF (5 
mL). The flask was cooled to –78 °C and (i-PrO)3TiCl (1 M solution in hexanes; 1.33 mL, 1.33 
mmol, 6.00 equiv) was added. MeLi (1.6 M solution in ether; 0.83 mL, 1.33 mmol, 6.00 equiv) 
was then added dropwise. This mixture was allowed to stir at –78 °C for 1 h. 26 (50 mg, 0.221 
mmol, 1.00 equiv) was then added as a solution in THF (5.5 mL). The reaction mixture was slowly 
warmed to 23 °C over 21h. The reaction was then carefully quenched with 1 M HCl (11 mL) and 
stirred vigorously for 30 min. The organic and aqueous layers were then separated, and the aqueous 
layer was extracted with EtOAc (12 mL x 4). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. The crude reaction mixture was purified by silica gel flash 
chromatography (0 → 4% MeOH/CH2Cl2) to afford 27 (37.5 mg, 76% yield, 22:1 dr)  
Rf = 0.43 (silica gel, 10% MeOH/CH2Cl2, UV, p-anisaldehyde) 
[α]D25 = +120.4° (c = 1.20, CHCl3).   
1H NMR (500 MHz, CDCl3): δ 7.29 (d, J = 5.6 Hz, 1H), 5.97 (d, J = 5.6 Hz, 1H), 2.79 (td, J = 
9.9, 8.9 Hz, 1H), 2.39 (dd, J = 9.8, 0.8 Hz, 1H), 1.93 (t, J = 10.4 Hz, 1H), 1.78 (ddd, J = 10.8, 8.9, 
1.0 Hz, 1H), 1.39 (s, 3H), 1.21 (s, 3H), 1.11 (s, 3H). 
(iPrO)3TiCl (6 equiv)
MeLi (6 equiv)
THF (0.02 M)
 –78ºC to rt, 21 h
(76% yield, 22:1 dr)
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13C NMR (101 MHz, CDCl3): δ 177.4, 172.9, 159.5, 120.5, 88.4, 46.9, 36.8, 35.5, 33.5, 29.9, 
23.6, 21.6. 
FTIR (NaCl, thin film, cm-1): 3091, 2936, 2958, 1869, 1741, 1702, 1464, 1454, 1417, 1371, 1282, 
1247, 1208, 1166, 1119, 1090, 1051, 956, 912, 820, 727, 661.  
HRMS (ESI-TOF, m/z): calc’d for C12H20NO4 [M+NH4]+: 242.1387; found: 242.1390. 
Hydrogenation of methylated products: preparation of 21 and SI-2 
 
 A 2-dram vial was charged with lactone 28 (29 mg, 0.129 mmol, 1.00 equiv) and Pd/C 
(10% by weight, 47 mg, 0.044 mmol, 0.34 equiv). The vial was then evacuated and backfilled with 
N2 three times. The solids were suspended in MeOH (1.4 mL, 0.095 M), and the reaction mixture 
was sparged with a balloon of H2 for 20 minutes at 0°C, at which point the balloon was replaced 
with a fresh balloon, and the reaction was allowed to warm to room temperature. The reaction 
mixture was then stirred for 7 h under an atmosphere of H2. Once the reaction was complete, the 
reaction mixture was sparged with argon for 20 minutes, diluted with EtOAc (15 mL), and filtered 
through celite, and concentrated in vacuo. The crude residue was then purified by silica gel flash 
chromatography (5% MeOH/CH2Cl2) to afford 21 (25 mg, 88% yield) as a white solid. 
Rf = 0.44 (silica gel, 10% MeOH/CH2Cl2, p-anisaldehyde) 
[α]D25 = +76.3° (c = 0.72, CHCl3).   
1H NMR (400 MHz, CDCl3): δ 2.91 (d, J = 9.7 Hz, 1H), 2.72 (t, J = 9.5 Hz, 1H), 2.70 – 2.59 (m, 
1H), 2.53 (ddd, J = 18.2, 9.6, 5.0 Hz, 1H), 2.04 – 1.86 (m, 2H), 1.67 (s, 1H), 1.65 (s, 1H), 1.30 (s, 
3H), 1.22 (s, 3H), 1.11 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 178.4, 177.1, 86.3, 86.3, 48.7, 39.1, 35.3, 32.6, 30.9, 29.9, 29.3, 
24.0, 23.7. 
FTIR (NaCl, thin film, cm-1): 2958, 2934, 2869, 1773, 1736, 1702, 1459, 1420, 1382, 1369, 1283, 
1248, 1166, 1142, 1077, 940, 914, 802, 646.  
HRMS (ESI-TOF, m/z): calc’d for C12H22NO4 [M+NH4]+: 244.1543; found: 244.1541. 
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27 (31.0 mg, 0.138 mmol, 1.00 equiv) was subjected to analogous conditions to afford SI-
2 (32.2 mg, quant yield), which was taken forward without further purification.  
Rf = 0.44 (silica gel, 10% MeOH/CH2Cl2, p-Anisaldehyde) 
[α]D25 = +51.2° (c = 0.53, CHCl3).   
1H NMR (400 MHz, CDCl3): δ 2.78 – 2.56 (m, 3H), 2.50 (ddd, J = 18.1, 9.9, 4.9 Hz, 1H), 2.17 – 
2.06 (m, 1H), 1.91 (ddd, J = 13.1, 10.0, 4.9 Hz, 1H), 1.81 (td, J = 9.8, 1.2 Hz, 1H), 1.71 (dd, J = 
10.8, 8.0 Hz, 1H), 1.29 (s, 3H), 1.21 (s, 3H), 1.11 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 178.4, 177.2, 86.5, 48.1, 39.2, 35.5, 33.6, 30.9, 29.9, 29.3, 23.9, 
23.7.  
FTIR (NaCl, thin film, cm-1): 2958, 2869, 1770, 1738, 1732, 1704, 1699, 1463, 1422, 1383, 1369, 
1283, 1245, 1222, 1165, 1138, 1075, 1002, 965, 941, 914, 802, 757, 711, 648.  
HRMS (ESI-TOF, m/z): calc’d for C12H22NO4 [M+NH4]+: 244.1543; found: 244.1537. 
 
Radical decarboxylative coupling to afford (+)-rumphellaone A (8) and epi-C8-rumphellaone 
A (29) 8 
 
 To a 2 dram vial charged with saturated lactone 21 (16 mg, 0.0707 mmol, 1.00 equiv) was 
added Ir[dF(CF3)ppy]2(dtbbpy)PF6 (0.8 mg, 0.0007 mmol, 0.01 equiv) and K2HPO4 (14.8 mg, 
0.0849 mmol, 1.20 equiv). The reaction vessel was evacuated and backfilled with N2 three times. 
DMF (0.71 mL, 0.1 M) was then added, and the reaction mixture was cooled to 0 °C and sparged 
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with argon for 15 minutes. Freshly distilled methyl vinyl ketone (7.2 µL, 0.0884 mmol, 1.25 equiv) 
was then added, and the reaction vessel was placed between two 34W blue LEDs (~5-6 cm away 
from each lamp) and stirred for 24 h with a small fan to keep the reactions at 23 ºC. Once complete, 
the reaction was diluted with sat. aq. NaHCO3 (0.8 mL) and EtOAc (0.8 mL). The layers were 
separated, and the aqueous layer was extracted with EtOAc (4 x 1 mL). The combined organic 
layers were washed with 1 M LiCl (5 mL). The organic layer was then dried over Na2SO4, filtered, 
and concentrated in vacuo. The crude material was purified by silica gel flash chromatography (20 
→ 40% EtOAc/hexanes) to afford pure (+)-rumphellaone A (8) (15 mg, 78% yield) as a yellow 
solid.  
Rf = 0.27 (silica gel, 40% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +43.4° (c = 0.35, CHCl3).   
1H NMR (400 MHz, CDCl3): δ 2.63 (ddd, J =18.1, 10.0, 8.9 Hz, 1H), 2.53 (ddd, J = 18.1, 10.0, 
5.0 Hz, 1H), 2.36 (t, J = 7.9 Hz, 2H), 2.12 (s, 3H), 2.09 – 2.02 (m, 2H), 2.03 – 1.97 (m, 1H), 1.90 
(ddd, J = 10.2, 9.6, 5.3 Hz, 2H), 1.88 – 1.81 (m, 1H), 1.69 – 1.61 (m, 2H), 1.57 (ddd, J = 10.8, 8.6, 
0.8 Hz, 1H), 1.42 (t, J = 10.3 Hz, 1H), 1.31 (s, 3H), 1.06 (s, 3H), 1.03 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 208.8, 177.1, 87.4, 44.6, 44.4, 42.1, 33.7, 33.1, 31.1, 30.8, 30.1, 
29.3, 25.2, 25.0, 22.6. 
FTIR (NaCl, thin film, cm-1): 2953, 2929, 2865, 1770, 1715, 1455, 1366, 1250, 1162, 1124, 1077, 
938, 803, 645. 
HRMS (ESI-TOF, m/z): calc’d for C15H25O3 [M+H]+: 253.1798; found: 253.1799. 
 
SI-2 (15.0 mg, 0.066 mmol, 1.00 equiv) was subjected to an analogous procedure to afford 
epi-C8-rumphellaone A (29) (8.1 mg, 52% yield) as a white solid. 
Rf = 0.33 (silica gel, 40% EtOAc/Hexanes, UV, p-anisaldehyde) 
[α]D25 = +38.5° (c = 0.41, CHCl3).   
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1H NMR (400 MHz, CDCl3): δ 2.63 – 2.56 (m, 2H), 2.39 (dd, J = 8.6, 6.6 Hz, 2H), 2.13 (s, 3H), 
2.10 – 1.96 (m, 2H), 1.90 (ddd, J = 13.0, 8.8, 7.2 Hz, 1H), 1.78 (tdd, J = 9.2, 6.6, 0.8 Hz, 1H), 1.71 
– 1.57 (m, 3H), 1.51 (t, J = 10.4 Hz, 1H), 1.29 (s, 3H), 1.06 (s, 3H), 1.03 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 208.7, 177.1, 87.3, 44.6, 44.1, 41.9, 34.5, 33.4, 31.6, 31.1, 30.2, 
29.3, 25.0, 24.0, 22.6. 
FTIR (NaCl, thin film, cm-1): 2952, 2932, 2865, 1769, 1715, 1455, 1422, 1365, 1234, 1169, 1155, 
1075, 963, 939, 801, 647. 
HRMS (ESI-TOF, m/z): calc’d for C15H25O3 [M+H]+: 253.1798; found: 253.1799. 
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Comparison of 1H NMR spectroscopic data for natural and synthetic (+)-rumphellaone A 
(8) (carbon numbering as reported by Sung et al.11) 
 
Carbon 
Number 
Natural (+)-rumphellaone A  
1H 400 MHz, CDCl3 
Synthetic (+)-rumphellaone A  
1H 400 MHz, CDCl3 
1 
1.91 (ddd, J = 10.0, 9.2, 5.6 Hz, 
2H) 1.90 (ddd, J = 10.2, 9.6, 5.3 Hz, 2H) 
2 1.67 (m, 2H) 1.65 (m, 2H) 
3 2.37 (t, J = 8.0 Hz, 2H) 2.36 (t, J = 7.9 Hz, 2H) 
6a 
2.63 (ddd, J = 18.0, 9.6, 8.8 Hz, 
1H) 2.63 (ddd, J =18.1, 10.0, 8.9 Hz, 1H) 
6b 
2.54 (ddd, J = 18.0, 10.0, 4.8 Hz, 
1H) 
2.53 (ddd, J = 18.1, 10.0, 5.0 Hz, 
1H) 
7⍺ 1.84 (m, 1H) 1.84 (m, 1H) 
7β 2.01 (m, 1H) 2.01 (m, 1H) 
9 2.06 (ddd, 10.4, 10.0, 10.0 Hz, 2H) 2.06 (m, 2H) 
10⍺ 1.57 (dd, J = 10.0, 10.0 Hz, 1H) 1.57 (ddd, J = 10.8, 8.6, 0.8 Hz, 1H) 
10β 1.42 (dd, J = 10.4, 10.0 Hz, 1H)) 1.42 (t, J = 10.3 Hz, 1H) 
12 2.13 (s, 3H) 2.12 (s, 3H) 
13 1.31 (s, 3H) 1.31 (s, 3H) 
14 1.03 (s, 3H) 1.03 (s, 3H) 
15 1.07 (s, 3H) 1.06 (s, 3H) 
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Comparison of 13C NMR spectroscopic data for natural and synthetic (+)-rumphellaone A 
(8). 
 
Carbon 
Number 
Natural (+)-rumphellaone 
A 13C 100 MHz, CDCl3 
Synthetic (+)-rumphellaone 
A 13C 101 MHz, CDCl3 Δ 
1 44.5 44.6 0.1 
2 25.1 25.2 0.1 
3 42.0 42.1 0.1 
4 208.6 208.8 0.2 
5 177.0 177.1 0.1 
6 29.2 29.3 0.1 
7 30.6 30.8 0.2 
8 87.2 87.4 0.2 
9 44.3 44.4 0.1 
10 33.6 33.7 0.1 
11 33.0 33.1 0.1 
12 29.9 30.1 0.2 
13 24.9 25.0 0.1 
14 22.5 22.6 0.1 
15 30.9 31.1 0.2 
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